Alhozali Amani, Alqutub Abdulsalam, Ahmed Mohammad S, Alsulami Omar A, Alfawaz Khaled, Faidah Hassan, AlNoury Omar, Alquliti Nawaf, Merdad Mazin
Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU.
Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU.
Cureus. 2023 Mar 2;15(3):e35703. doi: 10.7759/cureus.35703. eCollection 2023 Mar.
Background Hemithyroidectomy is a common procedure used to treat various benign and malignant conditions. It is often associated with complications, of which hypothyroidism is an underappreciated sequel. We sought to comprehend the rate and associated risk factors for developing hypothyroidism following hemithyroidectomy at King Abdulaziz University Hospital (KAUH). Methods In this retrospective study, we reviewed the medical records of all patients who had hemithyroidectomies for benign and malignant conditions between January 2008 and August 2022. Patients were analyzed for age, gender, body mass index (BMI), comorbidities, family history of thyroid disease, thyroid antibodies, and pre- and postoperative thyroid-stimulating hormone (TSH). Pre- and postoperative TSH levels were compared using the Wilcoxon signed-rank test. Results From 153 cases, 39 patients met the inclusion criteria; 31 (79.5%) were females. Seventeen (43.59%) patients developed biochemical hypothyroidism within two years following hemithyroidectomy; the majority (64.71%) of those with hypothyroidism developed it within the first six months. There was a significant increase in TSH levels following surgery (p < 0.001). Conclusion The overall incidence of hypothyroidism within two years of hemithyroidectomy is 43.59%; among those who developed hypothyroidism, the majority (64.71%) did so within the first six months. Thus, we strongly recommend continuous monitoring of TSH levels in the first six months, as it may aid in the decision to begin treatment before symptoms develop.
半甲状腺切除术是一种用于治疗各种良性和恶性疾病的常见手术。它常伴有并发症,其中甲状腺功能减退是一种未得到充分认识的后遗症。我们试图了解阿卜杜勒阿齐兹国王大学医院(KAUH)半甲状腺切除术后发生甲状腺功能减退的发生率及相关危险因素。方法:在这项回顾性研究中,我们回顾了2008年1月至2022年8月期间因良性和恶性疾病接受半甲状腺切除术的所有患者的病历。对患者的年龄、性别、体重指数(BMI)、合并症、甲状腺疾病家族史、甲状腺抗体以及术前和术后促甲状腺激素(TSH)进行分析。使用Wilcoxon符号秩检验比较术前和术后TSH水平。结果:在153例病例中,39例患者符合纳入标准;31例(79.5%)为女性。17例(43.59%)患者在半甲状腺切除术后两年内发生生化性甲状腺功能减退;甲状腺功能减退患者中的大多数(64.71%)在头六个月内发生。术后TSH水平显著升高(p < 0.001)。结论:半甲状腺切除术后两年内甲状腺功能减退的总体发生率为43.59%;在发生甲状腺功能减退的患者中,大多数(64.71%)在头六个月内发生。因此,我们强烈建议在头六个月内持续监测TSH水平,因为这可能有助于在症状出现前决定是否开始治疗。